Proteinase, phospholipase, biofilm forming abilities and antifungal susceptibilities of Malaysian Candida isolates from blood cultures

Medical Mycology

Volumn 49, Issue 5, 2011, Pages 556-560

  Tay, Sun Tee ^a   Abidin, Ira Azzura Zainal ^a   Hassan, Hamimah ^a   Ng, Kee Peng ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

antifungal susceptibility; biofilm; Candida; phospholipase; proteinase

Indexed keywords

AMPHOTERICIN; FLUCONAZOLE; PHOSPHOLIPASE; POLYSTYRENE; PROTEINASE;

ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BIOFILM; BLOOD CULTURE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA RUGOSA; CANDIDA TROPICALIS; HUMAN; MALAYSIA; MICROTITER PLATE ASSAY; NONHUMAN; PLANKTON; PROTEIN EXPRESSION; YEAST CELL;

ACADEMIC MEDICAL CENTERS; ANTIFUNGAL AGENTS; BIOFILMS; CANDIDA ALBICANS; CANDIDEMIA; HUMANS; MALAYSIA; MICROBIAL SENSITIVITY TESTS; PEPTIDE HYDROLASES; PHOSPHOLIPASES;

CANDIDA; CANDIDA ALBICANS;

EID: 79959263109     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.3109/13693786.2010.551424     Document Type: Article

References (24)

1. Colombo AL, Nucci M, Park BJ, et al. Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers. J Clin Microbiol 2006; 44: 2816-2823. (Pubitemid 44228575)
2. Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 2007; 20: 133-163. (Pubitemid 46167771)
3. Branchini ML, Pfaller MA, Rhine-Chalberg J, et al. Genotypic variation and slime production among blood isolates and catheter isolates of Candida parapsilosis. J Clin Microbiol 1994; 2: 452-456. (Pubitemid 24033911)
4. Nguyen MH, Peacock JE, Tanner DC, et al. Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study. Arch Intern Med 1995; 155: 2429-2435.
5. Trick WE, Fridkin SK, Edwards JR, et al. Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999. Clin Infect Dis 2002; 35: 627-630.
6. LaFleur MD, Kumamoto CA, Lewis K. Candida albicans biofilms produce antifungal-tolerant persister cells. Antimicrob Agents Chemother 2006; 50: 3839-3846. (Pubitemid 44684901)
7. Ghannoum MA. Potential role of phospholipases virulence and fungal pathogenesis. Clin Microbiol Rev 2000; 13: 122-143. (Pubitemid 30039346)
8. Naglik JR, Challacombe SJ, Hube B. Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Microbiol Mol Biol Rev 2003; 67: 400-428. (Pubitemid 37122527)
9. Schaller M, Borelli C, Korting HC, et al. Hydrolytic enzymes as virulence factors of Candida albicans. Mycoses 2005; 48: 365-377. (Pubitemid 43942679)
10. Ruma-Haynes P, Brownlee AG, Sorrell TC. A rapid method for detecting extracellular proteinase activity in Cryptococcus neoformans and a survey of 63 isolates. J Med Microbiol 2000; 49: 733-737. (Pubitemid 30623906)
11. Price MF, Wilkinson ID, Gentry LO. Plate method for detection of phospholipase activity in Candida albicans. Sabouraudia 1982; 20: 7-14. (Pubitemid 12161206)
12. Jin Y, Yip HK, Samaranayake YH, et al. Biofilm-forming ability of Candida albicans is unlikely to contributeto high levels of oral yeast carriage in cases of human immunodeficiency virus infection. J Clin Microbiol 2003; 41: 2961-2967. (Pubitemid 36842285)
13. Clinical and Laboratory Standards Institute. Method for Broth Dilution Testing of Yeasts , Approved Standard M27-A2, 2nd edn. Wayne, IN: Clinical and Laboratory Standards Institute, 2002.
14. Melo AS, Colombo AL, Arthington-Skaggs BA. Paradoxical growth effect of caspofungin observed on biofilms and planktonic cells of five different Candida species. Antimicrob Agents Chemother 2007; 51: 3081-3088. (Pubitemid 350067512)
15. Oksuz S, Sahin I, Yildirim M, Gulcan, et al. Phospholipase and proteinase activities in different Candida species isolated from anatomically distinct sites of healthy adults. Jpn J Infect Dis 2007; 60: 280-283. (Pubitemid 47516873)
16. Kantarcioglu AS, Yucel A. Phospholipase and protease activities in clinical Candida isolates with referenceto the sources of strains. Mycoses 2002; 45: 160-165. (Pubitemid 34743920)
17. Samaranayake LP, Raeside JM, MacFarlane TW. Factors affecting the phospholipase activity of Candida species in vitro. Sabouraudia 1984; 22: 201-207. (Pubitemid 14075279)
18. Ibrahim AS, Mirbod F, Filler SG, et al. Evidence implicating phospholipase as a virulence factor of Candida albicans. lnfect lmmun 1995; 63: 1993-1998.
19. Jain N, Kohli R, Cook E, et al. Biofilm formation by and antifungal susceptibility of Candida isolates from urine. Appl Envl Microbiol 2007; 73: 1697-1703. (Pubitemid 46449049)
20. Tumbarello M, Posteraro B, Trecarichi EM, et al. Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia. J Clin Microbiol 2007; 45: 1843-1850. (Pubitemid 46933916)
21. Hawser SP, Douglas LJ. Biofilm formation by Candida species on the surface of catheter materials in vitro. Infect Immun 1994; 62: 915-921. (Pubitemid 24065575)
22. Mendes A, Mores AU, Carvalho AP, et al. Candida albicans biofilms produce more secreted aspartyl proteasethan the planktonic c ells. Biol Pharm Bull 2007; 30: 1813-1815. (Pubitemid 47403267)
23. Ramage G, Vande Walle K, Wickes BL, Lopez-Ribot JL. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob Agents Chemother 2001; 45: 2475-2479. (Pubitemid 32801898)
24. Al-Dhaheri RS, Douglas LJ. Absence of amphotericin B-tolerant persister cells in biofilms of some Candida species. Antimicrob Agents Chemother 2008; 52: 1884-1887. (Pubitemid 351614696)